Facing the opposition

Article Abstract:

Elias Zerhouni is running the US National Institutes of Health at a crucial time in the agency's history and he plans to streamline the agency's management and sharpen its focus on clinical, interdisciplinary and technology-driven research. But his critics state that his vision is distracting the agency from its job of funding basic research.

Author: Check, Erika
Financial management, Executive changes & profiles, Medical Research, Epilepsy & Muscle Disease R&D, Administration of Public Health Programs, Health Research Programs, Officials and employees, Finance, Company financing, Medicine, Experimental, Zerhouni, Elias A.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Big money for cancer genomics

Article Abstract:

The US National institute of health is strongly supporting genomics in cancer research, and has launched a Human Cancer Genome Project that could take 10 years and cost US$ 1.5 billion. The pilot phase started is a crucial test for the institute, and for the genome scientists as it could help finding a drug.

Author: Check, Erika
Science & research, Cancer & Cell R&D, Research, Cancer research, Cancer, Cancer genetics, Oncology, Experimental

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Management, United States. National Institutes of Health, Company business management
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.